Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Relationships Between Infarct Growth, Clinical Outcome, and Early Recanalization in Diffusion and Perfusion Imaging for Understanding Stroke Evolution (DEFUSE)
2008
Active learning increases student performance in science, engineering, and mathematics
2014 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Stroke rehabilitation
2011 Standout
No health without mental health
2007 Standout
Metrics for Measuring Quality of Care in Comprehensive Stroke Centers: Detailed Follow-Up to Brain Attack Coalition Comprehensive Stroke Center Recommendations
2011
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial
2006
Structure of the TRPA1 ion channel suggests regulatory mechanisms
2015 StandoutNatureNobel
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
Imaging the penumbra – strategies to detect tissue at risk after ischemic stroke
2008
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study
2008
Inflammation and Hemostasis Biomarkers for Predicting Stroke in Postmenopausal Women: The Women's Health Initiative Observational Study
2008
Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial
2009
The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe
2010
Meta-Analysis of Transcatheter Closure Versus Medical Therapy for Patent Foramen Ovale in Prevention of Recurrent Neurological Events After Presumed Paradoxical Embolism
2012
Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke
2009
Intracerebral haemorrhage
2009 Standout
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
2009
Mechanical Embolectomy
2005
MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
2005
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
2013 Standout
Structural basis for triplet repeat disorders: a computational analysis
1999 StandoutNobel
Using Advanced MRI Techniques for Patient Selection Before Acute Stroke Therapy
2010
Pulse Pressure – Independent Predictor of Poor Early Outcome and Mortality following Ischemic Stroke
2008
Central nervous system injury-induced immune deficiency syndrome
2005 Standout
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
2008
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use
2009
New Antithrombotic Drugs
2012
Neuroprotection for ischemic stroke: Past, present and future
2008
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials
2007
Intravenous Recombinant Tissue Plasminogen Activator Improves Arterial Recanalization Rates and Reduces Infarct Volumes in Patients With Hyperdense Artery Sign on Baseline Computed Tomography
2008
Prostaglandin-Induced Activation of Nociceptive Neurons via Direct Interaction with Transient Receptor Potential A1 (TRPA1)
2007
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
In VitroIschemic Tolerance Involves Upregulation of Glutamate Transport Partly Mediated by the TACE/ADAM17-Tumor Necrosis Factor-α Pathway
2004
Taking a light approach to treating acute ischemic stroke patients: Transcranial near-infrared laser therapy translational science
2010
Silica-coated superparamagnetic iron oxide nanoparticles targeting of EPCs in ischemic brain injury
2013
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
2007 Standout
Alberta Stroke Program Early CT Score in Acute Stroke Triage
2005
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines
2006
CT Angiography Clot Burden Score and Collateral Score: Correlation with Clinical and Radiologic Outcomes in Acute Middle Cerebral Artery Infarct
2009
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
Neuroprotective Effects of Free Radical Scavengers in Stroke
2007
Diabetic Retinopathy
2012 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
2013 Standout
Aortic occlusion for cerebral ischemia: From theory to practice
2008
Associations of Inflammatory and Haemostatic Biomarkers with Poor Outcome in Acute Ischaemic Stroke
2009
A new penumbra: transitioning from injury into repair after stroke
2008
An Acute Ischemic Stroke Classification Instrument That Includes CT or MR Angiography: The Boston Acute Stroke Imaging Scale
2008
Stroke
2008 Standout
TRPA1 Contributes to Cold Hypersensitivity
2010 StandoutNobel
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2008 Standout
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
Experimental models, neurovascular mechanisms and translational issues in stroke research
2007
Residual Flow at the Site of Intracranial Occlusion on Transcranial Doppler Predicts Response to Intravenous Thrombolysis: A Multi-Center Study
2008
The neurovascular unit in the setting of stroke
2009
A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke
2002
Clinical interpretation and use of stroke scales
2006
Major Depressive Disorder
2008 Standout
Laser Therapy in Acute Stroke Treatment
2008
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
A role for tumor necrosis factor-α in ischemia and ischemic preconditioning
2011
A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: A need for more rigorous testing of neuroprotective agents in animal models of stroke
2007
Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive
2010
Optimal Outcome Measures for Detecting Clinical Benefits of Early Reperfusion: Insights from the DEFUSE Study
2008
Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke
2006
Symptomatic Intracerebral Hemorrhage following Thrombolytic Therapy for Acute Ischemic Stroke: A Review of the Risk Factors
2007
Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery
2007
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
2010 Standout
Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study
2006
High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial
2013
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI
2006
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways
2009 StandoutNobel
Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials
2007
Benefits of a Prehospital Stroke Code System
2004
The natural history of degenerative ataxia: a retrospective study in 466 patients
1998
Design of Poly(ethylene Glycol)-Functionalized Hydrophilic Carbon Clusters for Targeted Therapy of Cerebrovascular Dysfunction in Mild Traumatic Brain Injury
2012
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Recurrent cerebral ischemia in medically treated patent foramen ovale
2009
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
The 2007 Feinberg Lecture
2007
Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS)
2006
Purkinje Cell Expression of a Mutant Allele ofSCA1in Transgenic Mice Leads to Disparate Effects on Motor Behaviors, Followed by a Progressive Cerebellar Dysfunction and Histological Alterations
1997
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Therapeutic Hypothermia After Recanalization in Patients With Acute Ischemic Stroke
2013
Endovascular Recanalization Therapy in Acute Ischemic Stroke
2005
Safety and Tolerability of NXY-059 for Acute Intracerebral Hemorrhage
2007
Trends in Obesity Among Adults in the United States, 2005 to 2014
2016 Standout
A Pilot Study of Normobaric Oxygen Therapy in Acute Ischemic Stroke
2005
Luminescent Chemodosimeters for Bioimaging
2012 Standout
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
2006
Enhancing the Development and Approval of Acute Stroke Therapies
2005
Clinical Deterioration After Intravenous Recombinant Tissue Plasminogen Activator Treatment
2006
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Antioxidants in Central Nervous System Diseases: Preclinical Promise and Translational Challenges
2008
Initial Experience of a Digital Training Resource for Modified Rankin Scale Assessment in Clinical Trials
2007
Acute ischemic stroke
2009
Imaging perfusion deficits, arterial patency and thrombolysis safety and efficacy in acute ischaemic stroke. Anobservational study of the effect of advanced imaging methods in The Third International Stroke Trial (IST-3), arandomised controlled trial
2014
Long-Term Effect of Intra-Arterial Thrombolysis in Stroke
2006
Iron Withholding: A Defense Against Disease
2008
Shift Analysis Versus Dichotomization of the Modified Rankin Scale Outcome Scores in the NINDS and ECASS-II Trials
2007
Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke
2016
Acute stroke: evaluation and treatment.
2005
European Stroke Initiative Recommendations for Stroke Management – Update 2003
2003
Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage
2007
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Recombinant Tissue-Type Plasminogen Activator Plus Eptifibatide Versus Recombinant Tissue-Type Plasminogen Activator Alone in Acute Ischemic Stroke
2014
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
2005
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Current controversies in data monitoring for clinical trials
2006
Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia
2005
Recommendations for the Management of Cerebral and Cerebellar Infarction With Swelling
2014
Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention
2011
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
MR and CT Monitoring of Recanalization, Reperfusion, and Penumbra Salvage
2008
Statistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials
2007
Outcomes in Mild Acute Ischemic Stroke Treated With Intravenous Thrombolysis
2015
Infrared Laser Therapy for Ischemic Stroke: A New Treatment Strategy
2007
Recommendations for Imaging of Acute Ischemic Stroke
2009
Multimodal MRI for Ischemic Stroke: From Acute Therapy to Preventive Strategies
2009
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study Quality
2008
Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: A randomized clinical trial.
2013
Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials
2007 Standout
The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe
2018
Asymptomatic Hemorrhagic Transformation of Infarction and Its Relationship With Functional Outcome and Stroke Subtype
2010
An Updated Definition of Stroke for the 21st Century
2013 Standout
Effects of matrix metalloproteinase 9 inhibition on the blood brain barrier and inflammation in rats following cardiopulmonary resuscitation.
2009
Optimal Definition for PWI/DWI Mismatch in Acute Ischemic Stroke Patients
2008
Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke
2015
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
2009 Standout
Amphetamines for improving recovery after stroke
2007
Thrombolysis for acute ischaemic stroke
2014
The Impact of Recanalization on Ischemic Stroke Outcome
2007 Standout
Frequency of Increased Blood Pressure Levels During Systemic Thrombolysis and Risk of Intracerebral Hemorrhage
2011
Rapid Assessment of Perfusion–Diffusion Mismatch
2007
Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial
2007
Methodological Quality of Animal Studies of Neuroprotective Agents Currently in Phase II/III Acute Ischemic Stroke Trials
2008
Current Status of Neuroprotection for Cerebral Ischemia
2008
Mutation of the E6-AP Ubiquitin Ligase Reduces Nuclear Inclusion Frequency While Accelerating Polyglutamine-Induced Pathology in SCA1 Mice
1999 StandoutNobel
Works of Antonio Dávalos being referenced
Recurrent Stroke and Massive Right-to-Left Shunt
2008
High Serum Levels of Endothelin-1 Predict Severe Cerebral Edema in Patients With Acute Ischemic Stroke Treated With t-PA
2008
Eligibility for intravenous thrombolysis in acute stroke: A multicenter prospective study
2000
The release of tumor necrosis factor–α is associated with ischemic tolerance in human stroke
2003
High Blood Pressure and Inflammation Are Associated with Poor Prognosis in Lacunar Infarctions
2006
NXY-059 for the Treatment of Acute Ischemic Stroke
2007
NXY-059 for Acute Ischemic Stroke
2006
Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred
1995
The Purkinje cell in olivopontocerebellar atrophy. A Golgi and immunocytochemical study
1994
Unfractionated heparin is associated with a lower rise of serum vascular cell adhesion molecule-1 in acute ischemic stroke patients
2002
Safety and efficacy of desmoteplase given 3–9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial
2015
A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction
2002
Emerging Therapies for Cerebrovascular Disorders
2004
Increased Plasma Levels of 15-Deoxy Δ Prostaglandin J 2 Are Associated With Good Outcome in Acute Atherothrombotic Ischemic Stroke
2005
Increased Body Iron Stores Are Associated With Poor Outcome After Thrombolytic Treatment in Acute Stroke
2006
The Prediction of Malignant Cerebral Infarction by Molecular Brain Barrier Disruption Markers
2005
Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke
2000
The Increase of Circulating Endothelial Progenitor Cells After Acute Ischemic Stroke Is Associated With Good Outcome
2007
Additional Outcomes and Subgroup Analyses of NXY-059 for Acute Ischemic Stroke in the SAINT I Trial
2006
Levels of Anti-Inflammatory Cytokines and Neurological Worsening in Acute Ischemic Stroke
2003
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)
2004